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Introduction {#sec1}
============

Coenzyme B~12~, also known as adenosylcobalamin, plays an important role in several metabolic reactions occurring in different organ systems of the body ([@bib13]). For example, it is required for proper functioning of the nervous system and synthesis of red blood cells, fatty acids, and amino acids ([@bib21], [@bib26]). The demand for large-scale production of coenzyme B~12~ has steadily increased owing to its applications in food, feed additive, and pharmaceutical industries ([@bib9], [@bib8]). However, chemical synthesis of coenzyme B~12~ is highly complicated because of its complex structure. To overcome this shortcoming, industrial production of coenzyme B~12~ through microbial fermentation has been regarded as an efficient method ([@bib3]).

Currently, microorganisms with the inherent ability to synthesize coenzyme B~12~, including *Pseudomonas denitrificans* and *Propionibacterium freudenreichii* (the highest production was 214.3 *and* 206.0 mg/L, respectively), are widely employed for its industrial production ([@bib9], [@bib24], [@bib26]). However, these strains are not well characterized; thus, only limited engineering tools, such as random mutagenesis and plasmid-based gene expression, have been utilized ([@bib9], [@bib8], [@bib40]). In addition, these strains are known to have long fermentation cycles and expensive and complex medium requirements ([@bib8]).

The use of genetically well-characterized bacteria can be a compelling strategy for the production of coenzyme B~12~. In this regard, recent studies have reported the production of coenzyme B~12~ by exploiting the representative microbial workhorse, *Escherichia coli* ([@bib9], [@bib10], [@bib21]). It has been demonstrated that *E. coli* could be used to synthesize coenzyme B~12~ upon the addition of ado-cobinamide (AdoCbi) and dimethylbenzimidazole (DMBI) ([@bib10], [@bib18]) via the native coenzyme B~12~ salvage pathway ([@bib23]). Moreover, another group reconstructed the AdoCbi synthetic pathway from *P. denitrificans* and heterologously introduced it into *E. coli* BL21(DE3) ([@bib21]). In their study, Ko et al. overexpressed 22 genes using three plasmids; the production of coenzyme B~12~ (0.65 μg/g dry cell weight \[DCW\]) was confirmed even without the addition of AdoCbi. More recently, Fang et al. reported the production of unexpectedly high levels of coenzyme B~12~ (307.00 μg/g DCW) through step-by-step optimization of the synthetic pathway ([@bib9]). The entire synthetic pathway included heterologous expression of 28 genes, and the related genes from different microorganisms were screened for efficient production of coenzyme B~12~.

In addition to rational strain engineering strategies, selection-based engineering strategies have been valuable for improving the production capabilities of microorganisms. Indeed, recent studies have shown tremendous improvement in the biochemical production by devising genetic circuits with biosensors to detect metabolite levels of interest. Moreover, coupling the production capability with cell survival has led to a remarkable improvement in the titers ([@bib11], [@bib17]). For example, Xiao et al. have developed a circuit to control the expression of the genes responsible for antibiotic resistance or essential amino acid synthesis under the control of free fatty acid (FFA)-responsive promoter (P~AR~), only allowing the strains with active production of FFA to grow ([@bib39]). Consequently, it was highly effective to control the population quality by minimizing the heterogeneity in biological systems, thereby significantly enhancing the production of FFA. Similarly, Rugbjerg et al. have introduced a genetic circuit to couple the gene expression of cell wall synthesis with that of mevalonate production ([@bib33]); the introduction of the circuit enabled stable plasmid maintenance and consistent mevalonate production during long-term cultivation.

In the present study, an auxotrophic selection strategy was designed to increase the coenzyme B~12~ production in *E. coli*. We leveraged the characteristics of methionine biosynthesis in *E. coli*; *E. coli* was engineered to synthesize methionine only if coenzyme B~12~ existed with cobalamin-dependent homocysteine transmethylase (*metH*) by deleting the gene encoding for cobalamin-independent homocysteine transmethylase (*metE*). The growth rate of the *E. coli* strain lacking the gene *metE* was highly dependent on the concentration of exogenously added coenzyme B~12~. When the strategy was applied to the EpACR^cob^ strain, a previously reported coenzyme B~12~-producing strain ([@bib21]), the specific coenzyme B~12~ production was substantially improved by autonomous modulation of copy numbers of plasmids. The expression of *metH* was further varied to optimize the cell biomass and coenzyme B~12~ production. The engineered strain exhibited significantly enhanced coenzyme B~12~ production. We believe that this novel strategy would be useful not only for *E. coli*, but also for several other microorganisms for the production of coenzyme B~12~.

Results {#sec2}
=======

Construction of Coenzyme B~12~ Auxotroph System in *E. coli* {#sec2.1}
------------------------------------------------------------

To develop the auxotrophic selection strategy for the production of coenzyme B~12~, we initially sought an essential enzymatic reaction dependent on coenzyme B~12~ in *E. coli*. The most well-known enzyme is cobalamin-dependent homocysteine transmethylase (encoded by *metH*, [Figure 1](#fig1){ref-type="fig"}), which catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to L-homocysteine to produce methionine and tetrahydrofolate ([@bib22], [@bib28], [@bib31]). Coenzyme B~12~ is used as a direct mediator of the methyl group during the transfer process. In fact, *E. coli* possesses another cobalamin-independent enzyme, encoded by *metE*, to synthesize methionine ([@bib5], [@bib27]). Therefore, we decided to delete the *metE* gene in *E. coli* for auxotrophic selection. Additionally, we found an early stop codon at the 58th codon of *btuB* gene (KEGG number; ECD_03851, pseudogene encoding cobalamin outer membrane transporter) in the wild-type *E. coli* BL21(DE3) strain ([@bib38]), a host used in the previous coenzyme B~12~ production study ([@bib21]). Because it plays an essential role in coenzyme B~12~ import ([@bib10]), the early stop codon was replaced with "CAG" to incorporate glutamine, an identical codon used by other *E. coli* species (see the [Transparent Methods](#mmc1){ref-type="supplementary-material"} section); thus, the disrupt *btuB* gene was functionally expressed and the B~12~ auxotrophic growth was achieved following the addition of coenzyme B~12~.Figure 1Schematic Diagram of the Overall Strategies Used in the StudyThe synthetic coenzyme B~12~ auxotroph could be constructed by the deletion of chromosomal *metE* (encoding cobalamin-independent homocysteine transmethylase). The expression of *metH* (encoding cobalamin-dependent homocysteine transmethylase) was varied using different synthetic promoters to obtain optimal production of coenzyme B~12~. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Upon deleting *metE*, methionine is produced only by coenzyme B~12~-dependent MetH and the cells are able to grow in the presence of coenzyme B~12~. To validate the coenzyme B~12-~dependent cell growth, the resulting EDMB strain (*E. coli* BL21(DE3) with *metE* deletion and functional *btuB*, [Table S1](#mmc1){ref-type="supplementary-material"}) was cultured in the B~12~ auxotrophic medium containing all amino acids except methionine (see the [Transparent Methods](#mmc1){ref-type="supplementary-material"} section). As expected, the strain exhibited negligible growth (growth rate \<0.01 h^−1^) because of its inability to synthesize methionine. When the medium was supplemented with varying concentrations of coenzyme B~12~ ranging from 0 M to 1 μM (∼1.6 mg/L), the specific growth rate gradually increased as the concentration of coenzyme B~12~ was increased to 500 pM ([Figure 2](#fig2){ref-type="fig"}), reaching that of the wild-type (0.51 h^−1^) when a sufficient amount of coenzyme B~12~ was present. Although the range of concentrations where the auxotrophic selection functions are at the picomolar level, given that the production of coenzyme B~12~ is not high in *E. coli* ([@bib21]), it is expected to be applicable to producing strains. Collectively, these results suggest that the coenzyme B~12~ auxotrophic system was successfully constructed in *E. coli*.Figure 2The Validation of Coenzyme B~12~ Auxotrophic Cell Growth in the EDMB StrainThe specific cell growth rate (h^−1^) was calculated and plotted on the y axis according to the coenzyme B~12~ concentration (x axis). Error bars indicate the standard deviations from three independent cultures.

Application of Auxotrophic System for Coenzyme B~12~ Production {#sec2.2}
---------------------------------------------------------------

The auxotrophic system was applied to the previously reported coenzyme B~12~-producing strain, EpACR^cob^ ([Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). The three plasmids ([Table S1](#mmc1){ref-type="supplementary-material"}) harboring AdoCbi synthetic pathway genes from the EpACR^cob^ strain ([@bib21]) were introduced into the EDMB strain. The resulting EDMB^cob^ and EpACR^cob^ strains were initially cultured in the B~12~ auxotrophic medium; however, a severely reduced cell growth was observed for the EDMB^cob^ strain (the growth rate was 0.03 h^−1^). Therefore, we decided to use the RB~12~ medium containing 10 g/L of tryptone instead of the individual amino acids to supplement the low amount of methionine and to enhance the protein synthesis at the early phase of culture. This supplementation was helpful to obtain higher biomass (0.60 g DCW/L, [Figure 3](#fig3){ref-type="fig"}A). However, the deletion of *metE* still resulted in the formation of significantly reduced biomass of the EDMB^cob^ strain ([Figure 3](#fig3){ref-type="fig"}A, a 5.01-fold decrease). These results indicated that intracellular methionine synthesis was critical for cell growth and the EDMB^cob^ strain was still affected by the auxotrophic system.Figure 3The Effect of Synthetic Auxotrophic System on Coenzyme B~12~-Producing StrainsComparison of cell biomass (A) (See also [Figure S2](#mmc1){ref-type="supplementary-material"}), specific coenzyme B~12~ production (B), and plasmid copy number (PCN) after 12-h cultivation (C) (see also [Figure S3](#mmc1){ref-type="supplementary-material"}) and overall coenzyme B~12~ titer (D) after 24-h cultivation. Error bars indicate the standard deviations from experiments conducted in triplicate.

We further quantified the production of coenzyme B~12~ in both strains to investigate the effect of the selection strategy. The EpACR^cob^ strain exhibited higher production of coenzyme B~12~ (2.43 μg/g DCW) when compared with the previously reported value (0.65 μg/g DCW) ([@bib21]). Given that most of the culture conditions are the same, this difference in productivity is probably owing to the use of RB~12~ medium supplemented with glucose as a carbon source, unlike the previously used LB medium (see the [Transparent Methods](#mmc1){ref-type="supplementary-material"} section). Surprisingly, the EDMB^cob^ strain with the *metE* deletion showed a 2.73-fold increase in specific coenzyme B~12~ production compared with the EpACR^cob^ strain ([Figure 3](#fig3){ref-type="fig"}B, 6.64 μg/g DCW). The result indicates that the auxotrophic selection system was effective in significantly improving the production of coenzyme B~12~.

Because the only genomic differences are the deletion of *metE* and functional expression of *btuB*, it was hypothesized that the increase in the specific production could be attributed to the altered expression levels of AdoCbi synthetic genes. Plasmids typically exhibit a huge heterogeneity in their plasmid copy numbers (PCNs), which has often affected the production performance of microorganisms ([@bib16], [@bib19]). To test this hypothesis, the copy number of each plasmid in both strains was measured by quantitative PCR (qPCR). As mentioned, the copy numbers of the pCcob (ColA origin) and pRcob (RSF1030 origin) plasmids in the EpACR^cob^ strain ([Figure 3](#fig3){ref-type="fig"}C) were observed to be relatively lower (14.2 and 16.9 copies per cell, respectively) than that known (20--40 copies and 100 copies, respectively), which could be due to different culture conditions, use of multiple plasmids, and metabolic burden from several heterologous gene expression ([@bib16], [@bib41]). Meanwhile, the pACob plasmid (p15A origin) exhibited a significantly higher PCN (58.5 copies/cell) than the known PCN (10--12 copies/cell). Moreover, the high PCN of pAcob is consistent with the previously measured high mRNA levels of the genes in the pAcob plasmid ([@bib21]). The measurement revealed that the EDMB^cob^ strain showed dramatic changes in the copy number compared with the EpACR^cob^ strain. The copy number of the pCcob plasmid (26.6 copies/cell) was almost 2-fold higher than that in the EpACR^cob^ strain. The increased copy number of the pCcob plasmid led to enhanced expression of the genes responsible for converting hydrogenobyrinic acid a,c-diamide to AdoCbi ([Figure S1](#mmc1){ref-type="supplementary-material"}). On the contrary, PCN of both pAcob and pRcob plasmids (41.8 and 13.2 copies/cell, respectively) was 1.40-fold and 1.28-fold lower than that of the EpACR^cob^ strain. The decreased copy number might be beneficial to minimize the wasteful usage of resources in gene expression. There might be other potential factors; nevertheless, the introduction of the auxotrophic selection system affected PCNs, improving the production of coenzyme B~12.~

Optimization of *metH* Expression for Enhancing Coenzyme B~12~ Production {#sec2.3}
-------------------------------------------------------------------------

Despite the enhanced specific production, the volumetric titer of the EDMB^cob^ strain was lower than that of the EpACR^cob^ strain by 1.83-fold (3.98 μg/L, [Figure 3](#fig3){ref-type="fig"}D) because of the decreased cell biomass of the EDMB^cob^ strain. This result suggested that an additional tuning of the auxotrophic system was required to restore the cell biomass and thereby increase the overall titer.

It has been known that MetH has a higher catalytic efficiency than MetE ([@bib12]). However, methionine is mostly synthesized by MetE and not MetH because the expression of *metH* is induced only when cobalamin is present in the media ([@bib14], [@bib32]). Therefore, it was believed that reduced cell biomass of the EDMB^cob^ strain presumably resulted from insufficient methionine synthesis with low *metH* expression at an early stage of cultivation. To validate our assumption, the expression of *metH* was measured by qPCR ([Figure 4](#fig4){ref-type="fig"}). Indeed, the *metH* expression was very low at the beginning of the cultivation (4 h), reinforcing our assumption that this interfered with the early biomass accumulation. The expression of *metH* was subsequently induced after synthesis of coenzyme B~12~ (10 h); however, the cell biomass could not be recovered ([Figure S2](#mmc1){ref-type="supplementary-material"}). This is probably due to the metabolic imbalance that the proteins essential for cell growth could not be sufficiently synthesized along with the synthesis of numerous coenzyme B~12~ ([@bib4], [@bib34]). Collectively, this result suggested that increasing the *metH* expression would improve the initial cell growth as well as the overall titer.Figure 4Comparison of Normalized Amounts of *metH* Transcript in Engineered StrainsError bars indicate the standard deviations from experiments conducted in triplicate.

Therefore, we tried to deregulate the expression of *metH* using synthetic constitutive promoters (<http://parts.igem.org/Promoters/Catalog/Anderson>) ([@bib19], [@bib30], [@bib29]). To restore the cell biomass, the *metH* expression needed to be increased than before as its insufficient expression produced less cell biomass. However, excessive expression could also lower the specific coenzyme B~12~ production. Consequently, multiple strains with varied expression levels of *metH* were generated by introducing synthetic *metH* cassettes with different-strength constitutive promoters ([Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). The resultant strains (EDMB1-5^cob^) were cultivated, and the expression of *metH* was measured in the same manner ([Figure 4](#fig4){ref-type="fig"}). Although there was a gap between predicted strength and measured *metH* expression levels ([@bib15], [@bib20], [@bib29]), varied *metH* expression levels (up to 7.84-fold) were successfully identified in these engineered strains as intended. Moreover, these strains showed higher *metH* expression up to 28.6-fold than the EDMB^cob^ strain at an early stage of cultivation and appeared to maintain a relatively constant level during cultivation.

The synthetic expression of *metH* caused noticeable changes in both cell biomass and specific coenzyme B~12~ production. All engineered strains, EDMB1-5^cob^~,~ displayed notably increased cell biomass compared with the EDMB^cob^ strain ([Figures 3](#fig3){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}). In particular, the cell biomass was generally enhanced at 12 and 18 h as the expression of *metH* increased ([Figure S2](#mmc1){ref-type="supplementary-material"}), and almost 5-fold increased cell biomass was observed in all engineered strains at 24 h ([Figure 3](#fig3){ref-type="fig"}A). These values obtained at 24 h corresponded to the recovery of cell biomass to more than 90% of EpACR^cob^ strain without *metE* deletion. This indicated that sufficient methionine could be synthesized by the deregulated *metH* expression in engineered strains ([Figure 4](#fig4){ref-type="fig"}). On the contrary, specific coenzyme B~12~ production was decreased as a result of the enhanced *metH* expression ([Figure 3](#fig3){ref-type="fig"}B). Especially, specific production generally decreased as the *metH* expression increased, up to 1.78-fold for the EDMB5^cob^ strain with the highest *metH* expression as intended. Nevertheless, the significantly enhanced cell biomass increased the overall titer ([Figure 3](#fig3){ref-type="fig"}D). Among the strains, the EDMB2^cob^ strain with moderate *metH* expression level showed the highest coenzyme B~12~ production (13.2 μg/L), which was 3.31-fold and 1.80-fold higher than that of the EDMB^cob^ and EpACR^cob^ strains, respectively. In addition, the PCNs of EDMB1-5^cob^ strains showed a similar tendency as that of EDMB^cob^ strain ([Figure S3](#mmc1){ref-type="supplementary-material"}), indicating they were still affected by the synthetic auxotroph system. Collectively, these results show that the synthetic auxotroph system with precise controlled *metH* expression could be successfully applied to coenzyme B~12-~producing strains.

Discussion {#sec3}
==========

Recent studies have successfully demonstrated the production of coenzyme B~12~ in a well-known microbial workhorse *E. coli* ([@bib9], [@bib21]). However, the heterologous expression of synthetic genes has been an obstacle to further improvement. In the present study, a novel strategy to enhance the coenzyme B~12~ production was designed and applied to previously constructed coenzyme B~12-~producing *E. coli* ([@bib21]). Initially, the coenzyme B~12~ synthetic auxotrophic system was constructed using the characteristics of methionine synthesis in *E. coli*. Next, this system was applied to the previously reported producer strain to greatly improve the coenzyme B~12~ production. We found modulated copy numbers in the coenzyme B~12-~producing plasmids after the application of the auxotrophic selection system, which could explain the observed improvement in the production.

Optimizing complex metabolic pathways such as coenzyme B~12~ to enhance the production has been a labor-intensive work in metabolic engineering ([@bib37]). Our successful application of the auxotroph system, which could significantly enhance the coenzyme B~12~ production without optimization of individual gene expressions, suggests enough potential that the auxotroph system can be effectively used for complex pathway optimization. In addition, it was shown that the selection efficiency could be optimized through precisely regulating the expression of a key enzyme, which implies that the system can be optimized for different production levels like other selection-based strategies ([@bib33], [@bib39]).

The strategy would be applied to other coenzyme B~12~-producing strains such as *P. denitrificans* and *P. freudenreichii*. These strains also possess cobalamin-dependent homocysteine methyltransferase and are known to have a similar regulation system ([@bib1], [@bib7]). Given that these strains produce high amounts of coenzyme B~12~, the expression of cobalamin-dependent methyltransferase may need to be optimized at lower levels. Alternatively, the coenzyme B~12~-binding residues could be intentionally disrupted to lower the affinity base on the elucidated structure of cobalamin-dependent methyltransferase ([@bib6], [@bib35]). In addition, other cobalamin-dependent enzymes, such as methylmalonyl-CoA mutase (essential for odd-chain fatty acid synthesis) and glycerol dehydratase (essential for glycerol utilization), could be utilized using a similar strategy ([@bib2], [@bib28]). Moreover, these coenzyme B~12~ synthetic auxotrophic systems could be applied to evolutionary engineering approaches ([@bib25], [@bib36]). The short-term change in PCNs was validated to enhance the coenzyme B~12~ production in the current study; however, it could be used to screen genetically effective mutants as a powerful screening method in long-term evolution. Taken together, we expect our strategy to be widely applied for the efficient production of coenzyme B~12~.

Limitations of the Study {#sec3.1}
------------------------

The system described in the present study may be limited by the binding affinity of MetH to coenzyme B~12~. When this system is applied to a superior coenzyme B~12~-producing strain ([@bib9]), its operational range needs to be investigated or modified, if necessary. As discussed, the coenzyme B~12~-binding residues or expression levels can be altered for effective tuning of the dynamic range. Furthermore, other enzymes involved in different reactions could be considered also. Nonetheless, the improved coenzyme B~12~ production with our parental strain (EpACR^cob^) shows great potential. The present study could be valuable for understanding the heterogeneity during biochemical production and its minimization by introducing a selection strategy.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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